Cowen and Company, laddie posted this news on IV.
News
We have entered into a sales agreement with Cowen and Company, LLC, or Cowen, dated August 28, 2015, relating to shares of our common stock
offered by this prospectus supplement. In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock having an
aggregate offering price of up to $30,000,000 from time to time through Cowen acting as our agent.
Our common stock is listed on the Nasdaq Capital Market under the symbol "CPST." On August 27, 2015, the last reported sale price of our common
stock on the Nasdaq Capital Market was $0.37 per share.
Sales of our common stock, if any, under this prospectus supplement may be made in sales deemed to be "at-the-market" equity offerings as defined in
Rule 415 promulgated under the Securities Act of 1933, as amended, or the Securities Act, including sales made directly on or through the Nasdaq Capital
Market, the existing trading market for our common stock, sales made to or through a market maker other than on an exchange or otherwise, in negotiated
transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices and/or any other method permitted by law,
including in privately negotiated transactions. Cowen is not required to sell any specific number or dollar amount of securities, but will act as sales agent and
use commercially reasonable efforts to sell on our behalf all of the shares of common stock requested to be sold by us, consistent with its normal trading and
sales practices, on mutually agreed terms between Cowen and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.
Cowen will be entitled to compensation at a fixed commission rate of up to 3% of the gross sales price per share sold pursuant to the sales agreement. In
connection with the sale of our common stock on our behalf, Cowen may be deemed to be an "underwriter" within the meaning of the Securities Act and the
compensation of Cowen may be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to
Cowen with respect to certain liabilities, including liabilities under the Securities Act.
Investing in our securities involves risks. You should read this prospectus supplement and the accompanying prospectus carefully before you make
your investment decision. See "Risk Factors" beginning on page S-5 of this prospectus supplement, page 5 of the accompanying prospectus, as well as
the documents we file with the Securities and Exchange Commission that are incorporated by reference herein for more information.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed
upon the accuracy or adequacy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal......
